Clinical TrialID 1082
Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis
NCT01210989
Nonalcoholic Fatty Liver Disease
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 1082
- Evidence Id
- 1082
- Core Evidence Id
- 1082
- Source Clinical Trial Id
- 1064
- Herb2 Clinical Trial Id
- HBCT001064
- Nct Id
- NCT01210989
- Title
- Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Nonalcoholic Fatty Liver Disease
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Phyllanthus urinaria|DRUG: Placebo
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Quadruple
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 60
- Outcome Measure
- Histologic NAFLD activity score, week 24
- Sponsor Collaborator
- Chinese University of Hong Kong
- Funded By
- OTHER
- Location
- Cheng Suen Man Shook Hepatitis Center, Institute of Digestive Disease, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China
- Other Id
- NAFLD- Hepaguard
- Start Date
- 2010-05
- Primary Completion Date
- 2012-05
- Completion Date
- 2012-05
- First Posted
- 2010-09-29
- Results First Posted
- Last Update Posted
- 2014-02-24
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01210989
- Title Cn
- Title En
- Trial of Hepaguard® in Adults With Nonalcoholic Steatohepatitis
- Bilingual Status
- semi_complete